Wegovy’s Promise As An Effective Treatment For Obesity Now Depends On Insurers : Shots – Health News : NPR

In clinical trials, weekly injections of semaglutide — or Wegovy, as it’s been branded — helped people drop an average of 15% of their body weight. That’s an average of about 34 pounds over 16 months, before their weight plateaued — roughly triple what’s achieved with other drugs on the market. At least as important, Wegovy raised none of the alarm bells with the FDA or obesity doctors that it might trigger serious side effects of the sort some people experienced by taking fen-phen or other previous medical

Source: Wegovy’s Promise As An Effective Treatment For Obesity Now Depends On Insurers : Shots – Health News : NPR